{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:55:21Z","timestamp":1789646121418,"version":"4.0.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,9,30]],"date-time":"2017-09-30T00:00:00Z","timestamp":1506729600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s11940-017-0475-0","type":"journal-article","created":{"date-parts":[[2017,9,30]],"date-time":"2017-09-30T07:41:19Z","timestamp":1506757279000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Treatment of Blepharospasm\/Hemifacial Spasm"],"prefix":"10.1007","volume":"19","author":[{"given":"Kemar E.","family":"Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rastall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Eggenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,30]]},"reference":[{"issue":"8","key":"475_CR1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/qjmed\/95.8.493","volume":"95","author":"NN Tan","year":"2002","unstructured":"Tan NN. Hemifacial spasm and involuntary facial movements. QJM: monthly journal of the Association of Physicians. 2002;95(8):493.","journal-title":"QJM: monthly journal of the Association of Physicians"},{"key":"475_CR2","first-page":"151","volume":"49","author":"KK Digre","year":"1988","unstructured":"Digre KK. Hemifacial spasm: differential diagnosis, mechanism, and treatment. Adv Neurol. 1988;49:151.","journal-title":"Adv Neurol"},{"issue":"1\u20132","key":"475_CR3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jns.2004.04.004","volume":"222","author":"EE Tan","year":"2004","unstructured":"Tan EE. Clinico-radiologic correlation in unilateral and bilateral hemifacial spasm. J Neurol Sci. 2004;222(1\u20132):59.","journal-title":"J Neurol Sci"},{"issue":"2","key":"475_CR4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0022-510X(01)00651-7","volume":"193","author":"HH Miwa","year":"2002","unstructured":"Miwa HH. Familial hemifacial spasm: report of cases and review of literature. J Neurol Sci. 2002;193(2):97.","journal-title":"J Neurol Sci"},{"key":"475_CR5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-3-211-78205-7_18","volume":"101","author":"IBI Han","year":"2008","unstructured":"Han IBI. Supplement. The role of genetic factors in the development of hemifacial spasm: preliminary results. Acta Neurochir. 2008;101:107.","journal-title":"Acta Neurochir"},{"issue":"9","key":"475_CR6","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/mds.23692","volume":"26","author":"TCT Yaltho","year":"2011","unstructured":"Yaltho TCT. The many faces of hemifacial spasm: differential diagnosis of unilateral facial spasms. Mov Disord. 2011;26(9):1582.","journal-title":"Mov Disord"},{"issue":"1","key":"475_CR7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00701-015-2628-9","volume":"158","author":"MM Ohta","year":"2016","unstructured":"Ohta MM. Does arteriosclerosis contribute to hemifacial spasm? Acta Neurochir. 2016;158(1):181.","journal-title":"Acta Neurochir"},{"issue":"1","key":"475_CR8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1227\/01.neu.0000429838.38342.e2","volume":"73","author":"EE Refaee El","year":"2013","unstructured":"El Refaee EE. Value of 3-dimensional high-resolution magnetic resonance imaging in detecting the offending vessel in hemifacial spasm: comparison with intraoperative high definition endoscopic visualization. Neurosurgery. 2013;73(1):58.","journal-title":"Neurosurgery"},{"issue":"1","key":"475_CR9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5306\/wjco.v8.i1.86","volume":"8","author":"RAR Machado","year":"2017","unstructured":"Machado RAR. Intermittent facial spasms as the presenting sign of a recurrent pleomorphic adenoma. World journal of clinical oncology. 2017;8(1):86.","journal-title":"World journal of clinical oncology"},{"issue":"3","key":"475_CR10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archneur.63.3.441","volume":"63","author":"CC Colosimo","year":"2006","unstructured":"Colosimo CC. A comparative study of primary and secondary hemifacial spasm. Archives of neurology (Chicago). 2006;63(3):441.","journal-title":"Archives of neurology (Chicago)"},{"issue":"1","key":"475_CR11","doi-asserted-by":"crossref","first-page":"21082","DOI":"10.1038\/srep21082","volume":"6","author":"JJ Leong","year":"2016","unstructured":"Leong JJ. Revisiting the link between hypertension and hemifacial spasm. Sci Rep. 2016;6(1):21082.","journal-title":"Sci Rep"},{"issue":"2","key":"475_CR12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0895-7061(01)02288-9","volume":"15","author":"HH Hohenbleicher","year":"2002","unstructured":"Hohenbleicher HH. Neurovascular contact and blood pressure response in young, healthy, normotensive men. Am J Hypertens. 2002;15(2):119.","journal-title":"Am J Hypertens"},{"issue":"9","key":"475_CR13","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/01.wnl.0000183065.11255.15","volume":"65","author":"LLL Chan","year":"2005","unstructured":"Chan LLL. Ventrolateral medullary compression in hypertensive patients with hemifacial spasm. Neurology. 2005;65(9):1467.","journal-title":"Neurology"},{"issue":"1","key":"475_CR14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3171\/2011.7.JNS101378","volume":"116","author":"HDH Boogaarts","year":"2012","unstructured":"Boogaarts HDH. Primary hypertension and neurovascular compression: a meta-analysis of magnetic resonance imaging studies. J Neurosurg. 2012;116(1):147.","journal-title":"J Neurosurg"},{"issue":"6","key":"475_CR15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.pjnns.2014.09.006","volume":"48","author":"MM Rudzi\u0144ska","year":"2014","unstructured":"Rudzi\u0144ska MM. Small volume of the posterior cranial fossa and arterial hypertension are risk factors of hemifacial spasm. Neurol Neurochir Pol. 2014;48(6):383.","journal-title":"Neurol Neurochir Pol"},{"issue":"1","key":"475_CR16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12883-016-0634-z","volume":"16","author":"ECE Edmond","year":"2016","unstructured":"Edmond ECE. Vascular tortuosity in relationship with hypertension and posterior fossa volume in hemifacial spasm. BMC Neurol. 2016;16(1):120.","journal-title":"BMC Neurol"},{"issue":"5","key":"475_CR17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jocn.2006.04.010","volume":"14","author":"II Yamakami","year":"2007","unstructured":"Yamakami II. Hyperactivity of the facial nucleus produced by chronic electrical stimulation in rats. J Clin Neurosci. 2007;14(5):459.","journal-title":"J Clin Neurosci"},{"issue":"5","key":"475_CR18","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.clinph.2016.02.004","volume":"127","author":"SS Kameyama","year":"2016","unstructured":"Kameyama SS. Ephaptic transmission is the origin of the abnormal muscle response seen in hemifacial spasm. Clin Neurophysiol. 2016;127(5):2240.","journal-title":"Clin Neurophysiol"},{"issue":"7","key":"475_CR19","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.clineuro.2012.01.021","volume":"114","author":"JJ Zhong","year":"2012","unstructured":"Zhong JJ. A clinical analysis on microvascular decompression surgery in a series of 3000 cases. Clin Neurol Neurosurg. 2012;114(7):846.","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"475_CR20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ijsu.2011.02.010","volume":"9","author":"TT Ying","year":"2011","unstructured":"Ying TT. The value of abnormal muscle response monitoring during microvascular decompression surgery for hemifacial spasm. International journal of surgery (London, England). 2011;9(4):347.","journal-title":"International journal of surgery (London, England)"},{"issue":"7","key":"475_CR21","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1179\/1743132812Y.0000000057","volume":"34","author":"QQ Zhou","year":"2012","unstructured":"Zhou QQ. The role of autonomic nervous system in the pathophysiology of hemifacial spasm. Neurological research (New York). 2012;34(7):643.","journal-title":"Neurological research (New York)"},{"issue":"2","key":"475_CR22","first-page":"184","volume":"37","author":"NN Dou","year":"2015","unstructured":"Dou NN. The mechanism of hemifacial spasm: a new understanding of the offending artery. Neurological research (New York). 2015;37(2):184.","journal-title":"Neurological research (New York)"},{"issue":"12","key":"475_CR23","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/(SICI)1097-4598(199812)21:12<1740::AID-MUS17>3.0.CO;2-V","volume":"21","author":"AA Wang","year":"1998","unstructured":"Wang AA. Hemifacial spasm: clinical findings and treatment. Muscle Nerve. 1998;21(12):1740.","journal-title":"Muscle Nerve"},{"issue":"4","key":"475_CR24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.parkreldis.2004.12.003","volume":"11","author":"EE Tan","year":"2005","unstructured":"Tan EE. Behind the facial twitch: depressive symptoms in hemifacial spasm. Parkinsonism Relat Disord. 2005;11(4):241.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"475_CR25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1227\/01.NEU.0000348548.62440.42","volume":"65","author":"II Han","year":"2009","unstructured":"Han II. Unusual causes and presentations of hemifacial spasm. Neurosurgery. 2009;65(1):130.","journal-title":"Neurosurgery"},{"issue":"6","key":"475_CR26","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0194-5998(95)70026-9","volume":"113","author":"HPH Schwarze","year":"1995","unstructured":"Schwarze HPH. Oculostapedial synkinesis. Otolaryngol Head Neck Surg. 1995;113(6):802.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"475_CR27","first-page":"53","volume":"11","author":"CC Evinger","year":"2013","unstructured":"Evinger CC. Animal models for investigating benign essential blepharospasm. Curr Neuropharmacol. 2013;11(1):53.","journal-title":"Curr Neuropharmacol"},{"issue":"4","key":"475_CR28","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/mds.26934","volume":"32","author":"GG Defazio","year":"2017","unstructured":"Defazio GG. Blepharospasm 40 years later. Mov Disord. 2017;32(4):498.","journal-title":"Mov Disord"},{"issue":"4","key":"475_CR29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/WNO.0000000000000316","volume":"35","author":"KBK Digre","year":"2015","unstructured":"Digre KBK. Benign essential blepharospasm\u2014there is more to it than just blinking. J Neuroophthalmol. 2015;35(4):379.","journal-title":"J Neuroophthalmol"},{"issue":"6","key":"475_CR30","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp.51.6.767","volume":"51","author":"FF Grandas","year":"1988","unstructured":"Grandas FF. Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry. 1988;51(6):767.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"475_CR31","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/jnnp.2005.068007","volume":"77","author":"GG Defazio","year":"2006","unstructured":"Defazio GG. A family study on primary blepharospasm. J Neurol Neurosurg Psychiatry. 2006;77(2):252.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"14","key":"475_CR32","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/mds.25244","volume":"27","author":"TDT Steeves","year":"2012","unstructured":"Steeves TDT. The prevalence of primary dystonia: a systematic review and meta-analysis. Mov Disord. 2012;27(14):1789.","journal-title":"Mov Disord"},{"issue":"3","key":"475_CR33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1212\/WNL.0b013e31829bfdf6","volume":"81","author":"GG Defazio","year":"2013","unstructured":"Defazio GG. Development and validation of a clinical guideline for diagnosing blepharospasm. Neurology. 2013;81(3):236.","journal-title":"Neurology"},{"issue":"5","key":"475_CR34","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000341621","volume":"68","author":"AA Rana","year":"2012","unstructured":"Rana AA. Prevalence of blepharospasm and apraxia of eyelid opening in patients with parkinsonism, cervical dystonia and essential tremor. Eur Neurol. 2012;68(5):318.","journal-title":"Eur Neurol"},{"issue":"3","key":"475_CR35","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1468-1331.2010.03161.x","volume":"18","author":"ELE Peckham","year":"2011","unstructured":"Peckham ELE. Clinical features of patients with blepharospasm: a report of 240 patients. Eur J Neurol. 2011;18(3):382.","journal-title":"Eur J Neurol"},{"issue":"3","key":"475_CR36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000047975","volume":"47","author":"DD Martino","year":"2002","unstructured":"Martino DD. Menopause and menarche in patients with primary blepharospasm: an exploratory case-control study. Eur Neurol. 2002;47(3):161.","journal-title":"Eur Neurol"},{"issue":"4","key":"475_CR37","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/WNO.0000000000000317","volume":"35","author":"CC Evinger","year":"2015","unstructured":"Evinger CC. Benign essential blepharospasm is a disorder of neuroplasticity: lessons from animal models. J Neuroophthalmol. 2015;35(4):374.","journal-title":"J Neuroophthalmol"},{"issue":"1","key":"475_CR38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000453276","volume":"95","author":"JJ Lee","year":"2017","unstructured":"Lee JJ. Natural history of untreated hemifacial spasm: a study of 104 consecutive patients over 5 years. Stereotact Funct Neurosurg. 2017;95(1):21.","journal-title":"Stereotact Funct Neurosurg"},{"key":"475_CR39","first-page":"11","volume":"11","author":"P DAD","year":"2017","unstructured":"\u2022 DAD P. A dynamic circuit hypothesis for the pathogenesis of blepharospasm. Front Comput Neurosci. 2017;11:11. This paper proposes a new model for the pathophysiology of BEB, which may serve as a tool for implementing future therapeutic options.","journal-title":"Front Comput Neurosci"},{"issue":"11","key":"475_CR40","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1007\/s00415-013-7042-8","volume":"260","author":"JJ Yang","year":"2013","unstructured":"Yang JJ. Altered regional spontaneous neuronal activity in blepharospasm: a resting state fMRI study. J Neurol. 2013;260(11):2754.","journal-title":"J Neurol"},{"issue":"4","key":"475_CR41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mds.23011","volume":"25","author":"DD Martino","year":"2010","unstructured":"Martino DD. The phenomenology of the geste antagoniste in primary blepharospasm and cervical dystonia. Mov Disord. 2010;25(4):407.","journal-title":"Mov Disord"},{"key":"475_CR42","first-page":"45","volume":"7","author":"JJ Valls-Sole","year":"2016","unstructured":"Valls-Sole JJ. Blepharospasm: update on epidemiology, clinical aspects, and pathophysiology. Front Neurol. 2016;7:45.","journal-title":"Front Neurol"},{"issue":"24","key":"475_CR43","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1212\/WNL.0b013e318296e99d","volume":"80","author":"AA Conte","year":"2013","unstructured":"Conte AA. Is increased blinking a form of blepharospasm? Neurology. 2013;80(24):2236.","journal-title":"Neurology"},{"issue":"Suppl 2","key":"475_CR44","doi-asserted-by":"crossref","first-page":"s81","DOI":"10.1007\/s100720200080","volume":"23","author":"PP Lamberti","year":"2002","unstructured":"Lamberti PP. Frequency of apraxia of eyelid opening in the general population and in patients with extrapyramidal disorders. Neurol Sci. 2002;23(Suppl 2):s81.","journal-title":"Neurol Sci"},{"issue":"8","key":"475_CR45","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/mds.20919","volume":"21","author":"EME Weiss","year":"2006","unstructured":"Weiss EME. Relative risk of spread of symptoms among the focal onset primary dystonias. Mov Disord. 2006;21(8):1175.","journal-title":"Mov Disord"},{"issue":"4","key":"475_CR46","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/mds.26156","volume":"30","author":"GG Defazio","year":"2015","unstructured":"\u2022\u2022 Defazio GG. Development and validation of a clinical scale for rating the severity of blepharospasm. Mov Disord. 2015;30(4):525. This paper discusses the nuances of a more comprehensive clinical scale that better addresses BEB by taking into consideration the natural history of the disease.","journal-title":"Mov Disord"},{"issue":"Suppl 1","key":"475_CR47","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/j.parkreldis.2015.09.001","volume":"22","author":"AA Conte","year":"2016","unstructured":"Conte AA. Non-motor symptoms in patients with adult-onset focal dystonia: sensory and psychiatric disturbances. Parkinsonism Relat Disord. 2016;22(Suppl 1):S111.","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"475_CR48","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1468-1331.2009.02884.x","volume":"17","author":"LL Avanzino","year":"2010","unstructured":"Avanzino LL. Quality of sleep in primary focal dystonia: a case-control study. Eur J Neurol. 2010;17(4):576.","journal-title":"Eur J Neurol"},{"issue":"2","key":"475_CR49","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.parkreldis.2013.10.008","volume":"20","author":"RR Romano","year":"2014","unstructured":"Romano RR. Impaired cognitive functions in adult-onset primary cranial cervical dystonia. Parkinsonism Relat Disord. 2014;20(2):162.","journal-title":"Parkinsonism Relat Disord"},{"issue":"3\u20134","key":"475_CR50","first-page":"26","volume":"33","author":"RR Sandyk","year":"1987","unstructured":"Sandyk RR. Baclofen in hemifacial spasm. Int J Neurosci. 1987;33(3\u20134):26.","journal-title":"Int J Neurosci"},{"issue":"3","key":"475_CR51","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1212\/WNL.32.3.286","volume":"32","author":"GEG Alexander","year":"1982","unstructured":"Alexander GEG. Carbamazepine for hemifacial spasm. Neurology. 1982;32(3):286.","journal-title":"Neurology"},{"issue":"11","key":"475_CR52","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1212\/WNL.35.11.1676-a","volume":"35","author":"LL Herzberg","year":"1985","unstructured":"Herzberg LL. Management of hemifacial spasm with clonazepam. Neurology. 1985;35(11):1676.","journal-title":"Neurology"},{"issue":"2","key":"475_CR53","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1034\/j.1600-0404.2001.104002110.x","volume":"104","author":"OO Daniele","year":"2001","unstructured":"Daniele OO. Gabapentin in the treatment of hemifacial spasm. Acta Neurol Scand. 2001;104(2):110.","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"475_CR54","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000008068","volume":"42","author":"FF Bandini","year":"1999","unstructured":"Bandini FF. Gabapentin as treatment for hemifacial spasm. Eur Neurol. 1999;42(1):49.","journal-title":"Eur Neurol"},{"issue":"2","key":"475_CR55","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00002826-199619020-00008","volume":"19","author":"JJ Patel","year":"1996","unstructured":"Patel JJ. Gabapentin for the treatment of hemifacial spasm. Clin Neuropharmacol. 1996;19(2):185.","journal-title":"Clin Neuropharmacol"},{"issue":"11","key":"475_CR56","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1212\/01.WNL.0000127699.78939.73","volume":"62","author":"DD Deleu","year":"2004","unstructured":"Deleu DD. Levetiracetam in the treatment of idiopathic hemifacial spasm. Neurology. 2004;62(11):2134.","journal-title":"Neurology"},{"issue":"3","key":"475_CR57","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/WNF.0b013e3180ed44c8","volume":"31","author":"PP Biagio Carrieri","year":"2008","unstructured":"Biagio Carrieri PP. Efficacy of levetiracetam in hemifacial spasm: a case report. Clin Neuropharmacol. 2008;31(3):187.","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"475_CR58","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/WNF.0b013e31819a68dc","volume":"32","author":"AA Siniscalchi","year":"2009","unstructured":"Siniscalchi AA. Idiopathic hemifacial spasm responsive to zonisamide: a case report. Clin Neuropharmacol. 2009;32(4):230.","journal-title":"Clin Neuropharmacol"},{"key":"475_CR59","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jocn.2016.05.025","volume":"34","author":"TT Kuroda","year":"2016","unstructured":"Kuroda TT. Efficacy of levetiracetam in primary hemifacial spasm. J Clin Neurosci. 2016;34:213.","journal-title":"J Clin Neurosci"},{"key":"475_CR60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2016.11.029","volume":"372","author":"DD Vijayakumar","year":"2017","unstructured":"Vijayakumar DD. Treatment of blepharospasm with apraclonidine. J Neurol Sci. 2017;372:57.","journal-title":"J Neurol Sci"},{"key":"475_CR61","first-page":"207","volume":"37","author":"SMS Gollomp","year":"1983","unstructured":"Gollomp SMS. Therapeutic trials in Meige syndrome. Adv Neurol. 1983;37:207.","journal-title":"Adv Neurol"},{"issue":"2","key":"475_CR62","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1212\/WNL.34.2.215","volume":"34","author":"JGJ Nutt","year":"1984","unstructured":"Nutt JGJ. Cranial dystonia: double-blind crossover study of anticholinergics. Neurology. 1984;34(2):215.","journal-title":"Neurology"},{"issue":"4","key":"475_CR63","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ana.410050418","volume":"5","author":"JRJ Merikangas","year":"1979","unstructured":"Merikangas JRJ. Blepharospasm: successful treatment with clonazepam. Ann Neurol. 1979;5(4):401.","journal-title":"Ann Neurol"},{"issue":"1","key":"475_CR64","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/1531-8257(199901)14:1<173::AID-MDS1035>3.0.CO;2-X","volume":"14","author":"SS Ohara","year":"1999","unstructured":"Ohara SS. Mexiletine in the treatment of blepharospasm: experience with the first three patients. Mov Disord. 1999;14(1):173.","journal-title":"Mov Disord"},{"issue":"1","key":"475_CR65","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ana.410110108","volume":"11","author":"JJ Jankovic","year":"1982","unstructured":"Jankovic JJ. Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study. Ann Neurol. 1982;11(1):41.","journal-title":"Ann Neurol"},{"issue":"2","key":"475_CR66","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10072-011-0672-7","volume":"33","author":"B ARA","year":"2012","unstructured":"\u2022\u2022 ARA B. Retrospective evaluation of the dose equivalence of Botox(\u00ae) and Dysport (\u00ae) in the management of blepharospasm and hemifacial spasm: a novel paradigm for a never ending story. Neurol Sci. 2012;33(2):261. This retrospective analysis thoroughly evaluates the factors that limit the determination of a true dose equivalent between ONA and ABO in the treatment of both BEB and HFS.","journal-title":"Neurol Sci"},{"issue":"1","key":"475_CR67","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/IOP.0000000000000405","volume":"32","author":"TJT Broadbent","year":"2016","unstructured":"Broadbent TJT. A survey of current blepharospasm treatment patterns among oculoplastic surgeons. Ophthal Plast Reconstr Surg. 2016;32(1):24.","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"19","key":"475_CR68","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1212\/01.wnl.0000311389.26145.95","volume":"70","author":"S DMD","year":"2008","unstructured":"\u2022\u2022 DMD S. Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008;70(19):1699. This paper provides the most recent clinical recommendations made by the AAN regarding the use of BTX injections in the treatment of HFS.","journal-title":"Neurology"},{"key":"475_CR69","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.toxicon.2012.12.004","volume":"67","author":"MM Hallett","year":"2013","unstructured":"Hallett MM. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. Toxicon (Oxford). 2013;67:94.","journal-title":"Toxicon (Oxford)"},{"issue":"19","key":"475_CR70","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","volume":"86","author":"S DMD","year":"2016","unstructured":"\u2022\u2022 DMD S. Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2016;86(19):1818. This paper provides the most recent clinical recommendations made by the AAN regarding the use of BTX injections in the treatment of BEB.","journal-title":"Neurology"},{"key":"475_CR71","doi-asserted-by":"crossref","first-page":"286","DOI":"10.5334\/tohm.186","volume":"4","author":"DD Martinez-Ramirez","year":"2014","unstructured":"Martinez-Ramirez DD. Comparable botulinum toxin outcomes between primary and secondary blepharospasm: a retrospective analysis. Tremor and other hyperkinetic movements (New York, NY). 2014;4:286.","journal-title":"Tremor and other hyperkinetic movements (New York, NY)"},{"issue":"41","key":"475_CR72","first-page":"667","volume":"109","author":"CC Rosenstengel","year":"2012","unstructured":"Rosenstengel CC. Hemifacial spasm: conservative and surgical treatment options. Dtsch Arztebl Int. 2012;109(41):667.","journal-title":"Dtsch Arztebl Int"},{"key":"475_CR73","doi-asserted-by":"crossref","first-page":"e0168652","DOI":"10.1371\/journal.pone.0168652","volume":"11","author":"AA Hanganu","year":"2016","unstructured":"Hanganu AA. Grey matter microstructural integrity alterations in blepharospasm are partially reversed by botulinum neurotoxin therapy. Public library of science. PLoS One. 2016;11:e0168652.","journal-title":"PLoS One"},{"issue":"2","key":"475_CR74","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1523\/JNEUROSCI.3948-05.2006","volume":"26","author":"AA Quartarone","year":"2006","unstructured":"Quartarone AA. Enhanced long-term potentiation-like plasticity of the trigeminal blink reflex circuit in blepharospasm. J Neurosci. 2006;26(2):716.","journal-title":"J Neurosci"},{"issue":"6","key":"475_CR75","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/mds.870120627","volume":"12","author":"CC Sampaio","year":"1997","unstructured":"Sampaio CC. DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A\u2014Dysport and Botox\u2014assuming a ratio of 4:1. Mov Disord. 1997;12(6):1013.","journal-title":"Mov Disord"},{"key":"475_CR76","doi-asserted-by":"crossref","first-page":"238","DOI":"10.5334\/tohm.181","volume":"4","author":"HHH Fernandez","year":"2014","unstructured":"Fernandez HHH. Observational study of incobotulinumtoxinA for cervical dystonia or blepharospasm (XCiDaBLE): interim results for the first 170 subjects with blepharospasm. Tremor and other hyperkinetic movements (New York, N.Y.). 2014;4:238.","journal-title":"Tremor and other hyperkinetic movements (New York, N.Y.)"},{"issue":"Suppl 3","key":"475_CR77","first-page":"S48","volume":"95","author":"SS Kongsengdao","year":"2012","unstructured":"Kongsengdao SS. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study. J Med Assoc Thail. 2012;95(Suppl 3):S48.","journal-title":"J Med Assoc Thail"},{"issue":"1","key":"475_CR78","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1055\/s-0036-1571952","volume":"36","author":"BIB Karp","year":"2016","unstructured":"Karp BIB. Botulinum toxin treatment of blepharospasm, orofacial\/oromandibular dystonia, and hemifacial spasm. Semin Neurol. 2016;36(1):84.","journal-title":"Semin Neurol"},{"issue":"6","key":"475_CR79","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00702-010-0409-4","volume":"117","author":"KK Kollewe","year":"2010","unstructured":"Kollewe KK. Hemifacial spasm and reinnervation synkinesias: long-term treatment with either Botox or Dysport. Journal of neural transmission (Vienna, Austria : 1996). 2010;117(6):759.","journal-title":"Journal of neural transmission (Vienna, Austria : 1996)"},{"issue":"1","key":"475_CR80","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/PL00007849","volume":"249","author":"RR Cakmur","year":"2002","unstructured":"Cakmur RR. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neurol. 2002;249(1):64.","journal-title":"J Neurol"},{"issue":"9","key":"475_CR81","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3109\/00016489.2016.1165864","volume":"136","author":"WJW Choe","year":"2016","unstructured":"Choe WJW. Increasing the area and varying the dosage of botulinum toxin a injections for effective treatment of hemifacial spasm. Acta Otolaryngol. 2016;136(9):952.","journal-title":"Acta Otolaryngol"},{"issue":"3","key":"475_CR82","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00702-014-1278-z","volume":"122","author":"KK Kollewe","year":"2015","unstructured":"\u2022\u2022 Kollewe KK. Blepharospasm: long-term treatment with either Botox\u00ae, Xeomin\u00ae or Dysport\u00ae. Journal of neural transmission (Vienna, Austria : 1996). 2015;122(3):427. One of the first and largest long-term studies comparing the different formulations of BTX in the treatment of BEB. The study also validated the increase efficacy of using shorter inter-injection periods.","journal-title":"Journal of neural transmission (Vienna, Austria : 1996)"},{"issue":"1","key":"475_CR83","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.survophthal.2006.10.003","volume":"52","author":"JJJ Dutton","year":"2007","unstructured":"Dutton JJJ. Botulinum toxin in ophthalmology. Surv Ophthalmol. 2007;52(1):13.","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"475_CR84","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1590\/0004-282x20160191","volume":"75","author":"JPMJ Batisti","year":"2017","unstructured":"Batisti JPMJ. Treatment of hemifacial spasm with botulinum toxin type a: effective, long lasting and well tolerated. Arq Neuropsiquiatr. 2017;75(2):87.","journal-title":"Arq Neuropsiquiatr"},{"issue":"3","key":"475_CR85","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/ceo.12165","volume":"42","author":"OHO Ababneh","year":"2014","unstructured":"Ababneh OHO. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm. Clinical & experimental ophthalmology. 2014;42(3):254.","journal-title":"Clinical & experimental ophthalmology"},{"issue":"9","key":"475_CR86","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00702-013-0998-9","volume":"120","author":"DDD Truong","year":"2013","unstructured":"Truong DDD. Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(\u00ae)) injections in blepharospasm. Journal of neural transmission (Vienna, Austria : 1996). 2013;120(9):1345.","journal-title":"Journal of neural transmission (Vienna, Austria : 1996)"},{"issue":"pt a","key":"475_CR87","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.toxicon.2015.09.037","volume":"107","author":"OOO Ojo","year":"2015","unstructured":"Ojo OOO. Is it time for flexibility in botulinum inter-injection intervals? Toxicon (Oxford). 2015;107(pt a):72.","journal-title":"Toxicon (Oxford)"},{"key":"475_CR88","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jns.2016.05.033","volume":"367","author":"JJ Fezza","year":"2016","unstructured":"Fezza JJ. A cross-sectional structured survey of patients receiving botulinum toxin type A treatment for blepharospasm. J Neurol Sci. 2016;367:56.","journal-title":"J Neurol Sci"},{"issue":"8","key":"475_CR89","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jocn.2015.02.032","volume":"22","author":"S MHM","year":"2015","unstructured":"\u2022\u2022 MHM S. Botulinum toxin injections for the treatment of hemifacial spasm over 16 years. J Clin Neurosci. 2015;22(8):1319. This retrospective analysis provides valuable data on the treatment of HFS with BTX, including validation of the preferred injection site.","journal-title":"J Clin Neurosci"},{"issue":"11","key":"475_CR90","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s10072-016-2670-2","volume":"37","author":"LL Xiao","year":"2016","unstructured":"Xiao LL. Facial asymmetry in patients with hemifacial spasm before and after botulinum toxin A treatment. Neurol Sci. 2016;37(11):1807.","journal-title":"Neurol Sci"},{"issue":"Suppl 8","key":"475_CR91","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1002\/mds.20020","volume":"19","author":"MZM Atassi","year":"2004","unstructured":"Atassi MZM. Basic immunological aspects of botulinum toxin therapy. Mov Disord. 2004;19(Suppl 8):S68.","journal-title":"Mov Disord"},{"issue":"3","key":"475_CR92","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1185\/030079905X36396","volume":"21","author":"KK Bihari","year":"2005","unstructured":"Bihari KK. Safety, effectiveness, and duration of effect of Botox after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm. Curr Med Res Opin. 2005;21(3):433.","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"475_CR93","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/IOP.0000000000000443","volume":"32","author":"RVR Chundury","year":"2016","unstructured":"Chundury RVR. Subjective and objective measures in the treatment of hemifacial spasm with onabotulinumtoxinA. Ophthal Plast Reconstr Surg. 2016;32(2):133.","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"2","key":"475_CR94","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0161-6420(98)93484-4","volume":"105","author":"JDJ Wirtschafter","year":"1998","unstructured":"Wirtschafter JDJ. Long-term efficacy of local doxorubicin chemomyectomy in patients with blepharospasm and hemifacial spasm. Ophthalmology (Rochester, Minn). 1998;105(2):342.","journal-title":"Ophthalmology (Rochester, Minn)"},{"issue":"5","key":"475_CR95","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/mus.23800","volume":"48","author":"RFR Sekula","year":"2013","unstructured":"Sekula RFR. Microvascular decompression for hemifacial spasm in patients >65 years of age: an analysis of outcomes and complications. Muscle Nerve. 2013;48(5):770.","journal-title":"Muscle Nerve"},{"issue":"4","key":"475_CR96","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3109\/02688697.2011.641613","volume":"26","author":"LEL Miller","year":"2012","unstructured":"Miller LEL. Safety and effectiveness of microvascular decompression for treatment of hemifacial spasm: a systematic review. Br J Neurosurg. 2012;26(4):438.","journal-title":"Br J Neurosurg"},{"issue":"3","key":"475_CR97","doi-asserted-by":"crossref","first-page":"493","DOI":"10.4103\/neuroindia.NI_1166_16","volume":"65","author":"RR Sharma","year":"2017","unstructured":"\u2022\u2022 Sharma RR. Microvascular decompression for hemifacial spasm: a systematic review of vascular pathology, long term treatment efficacy and safety. Neurol India. 2017;65(3):493. The largest meta-analysis studying the long-term clinical utility of MVD in HFS patients. The review provides the best analysis of complication rates from the procedure. It also identifies the AICA as the most common offending vessel.","journal-title":"Neurol India"},{"issue":"3","key":"475_CR98","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00701-013-1941-4","volume":"156","author":"MM Ohta","year":"2014","unstructured":"Ohta MM. Preoperative assessment of hemifacial spasm by the coronal heavily T2-weighted MR cisternography. Acta Neurochir. 2014;156(3):565.","journal-title":"Acta Neurochir"},{"issue":"4","key":"475_CR99","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00062-015-0382-2","volume":"26","author":"JJ Jia","year":"2016","unstructured":"Jia JJ. Preoperative evaluation of patients with hemifacial spasm by three-dimensional time-of-flight (3D-TOF) and three-dimensional constructive interference in steady state (3D-CISS) sequence. Clin Neuroradiol. 2016;26(4):431.","journal-title":"Clin Neuroradiol"},{"issue":"9","key":"475_CR100","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00701-013-1724-y","volume":"155","author":"AA Fukunaga","year":"2013","unstructured":"Fukunaga AA. A recommendation on the basis of long-term follow-up results of our microvascular decompression operation for hemifacial spasm. Acta Neurochir. 2013;155(9):1693.","journal-title":"Acta Neurochir"},{"key":"475_CR101","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.wneu.2017.04.059","volume":"103","author":"YY Nagata","year":"2017","unstructured":"Nagata YY. The \u201cmulti-scope technique\u201d for microvascular decompression. World neurosurgery. 2017;103:310.","journal-title":"World neurosurgery"},{"issue":"2","key":"475_CR102","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00701-014-2294-3","volume":"157","author":"MM Ishikawa","year":"2015","unstructured":"Ishikawa MM. Microvascular decompression under neuroendoscopic view in hemifacial spasm: rostral-type compression and perforator-type compression. Acta Neurochir. 2015;157(2):329.","journal-title":"Acta Neurochir"},{"issue":"1","key":"475_CR103","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-0037-1599799","volume":"78","author":"PDP Thirumala","year":"2017","unstructured":"Thirumala PDP. Part B, skull base: brainstem auditory evoked potentials\u2019 diagnostic accuracy for hearing loss: systematic review and meta-analysis. Journal of neurological surgery. 2017;78(1):43.","journal-title":"Journal of neurological surgery"},{"key":"475_CR104","doi-asserted-by":"crossref","unstructured":"Liu MXM. The significance of abnormal muscle response monitoring during microvascular decompression for hemifacial spasm. Acta Neurochir Suppl. 2017;124:297.","DOI":"10.1007\/978-3-319-39546-3_43"},{"key":"475_CR105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijsu.2016.12.032","volume":"38","author":"CC Huang","year":"2017","unstructured":"Huang CC. An optimized abnormal muscle response recording method for intraoperative monitoring of hemifacial spasm and its long-term prognostic value. International journal of surgery (London, England). 2017;38:67.","journal-title":"International journal of surgery (London, England)"},{"issue":"3","key":"475_CR106","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10143-016-0708-9","volume":"39","author":"AA Damaty El","year":"2016","unstructured":"El Damaty AA. The value of lateral spread response monitoring in predicting the clinical outcome after microvascular decompression in hemifacial spasm: a prospective study on 100 patients. Neurosurg Rev. 2016;39(3):455.","journal-title":"Neurosurg Rev"},{"issue":"6","key":"475_CR107","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00701-014-2055-3","volume":"156","author":"HH Sun","year":"2014","unstructured":"Sun HH. The strategy of microvascular decompression for hemifacial spasm: how to decide the endpoint of an MVD surgery. Acta Neurochir. 2014;156(6):1155.","journal-title":"Acta Neurochir"},{"issue":"6","key":"475_CR108","first-page":"158","volume":"67","author":"CC Kim","year":"2010","unstructured":"Kim CC. The potential value of the disappearance of the lateral spread response during microvascular decompression for predicting the clinical outcome of hemifacial spasms: a prospective study. Neurosurgery. 2010;67(6):158.","journal-title":"Neurosurgery"},{"issue":"5","key":"475_CR109","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.otc.2005.03.016","volume":"38","author":"BCKB Patel","year":"2005","unstructured":"Patel BCKB. Surgical management of essential blepharospasm. Otolaryngol Clin N Am. 2005;38(5):1075.","journal-title":"Otolaryngol Clin N Am"},{"issue":"5","key":"475_CR110","first-page":"488","volume":"24","author":"BB Pariseau","year":"2013","unstructured":"Pariseau BB. Myectomy for blepharospasm 2013. Curr Opin Ophthalmol. 2013;24(5):488.","journal-title":"Curr Opin Ophthalmol"},{"issue":"3","key":"475_CR111","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ajo.2007.10.017","volume":"145","author":"DD Georgescu","year":"2008","unstructured":"Georgescu DD. Upper eyelid myectomy in blepharospasm with associated apraxia of lid opening. Am J Ophthalmol. 2008;145(3):541.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"475_CR112","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/IOP.0000000000000263","volume":"31","author":"TLT Kent","year":"2015","unstructured":"Kent TLT. Effect of upper eyelid myectomy on subsequent chemodenervation in the management of benign essential blepharospasm. Ophthal Plast Reconstr Surg. 2015;31(3):222.","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"4","key":"475_CR113","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/mds.23549","volume":"26","author":"RR Reese","year":"2011","unstructured":"Reese RR. Long-term clinical outcome in Meige syndrome treated with internal pallidum deep brain stimulation. Mov Disord. 2011;26(4):691.","journal-title":"Mov Disord"},{"key":"475_CR114","doi-asserted-by":"publisher","unstructured":"Yamada K. Pallidal stimulation for medically intractable blepharospasm. BMJ Case Rep. 2016. https:\/\/doi.org\/10.1136\/bcr-2015-214241 .","DOI":"10.1136\/bcr-2015-214241"},{"issue":"16","key":"475_CR115","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1212\/WNL.0b013e3181f8814d","volume":"75","author":"GG Kranz","year":"2010","unstructured":"\u2022 Kranz GG. Transcranial magnetic brain stimulation modulates blepharospasm: a randomized controlled study. Neurology. 2010;75(16):1465. The study provides class II evidence that rTMS provides a safe and efficacious option for the treatment of BEB","journal-title":"Neurology"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-017-0475-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-017-0475-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-017-0475-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T14:38:15Z","timestamp":1603031895000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-017-0475-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,30]]},"references-count":115,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["475"],"URL":"https:\/\/doi.org\/10.1007\/s11940-017-0475-0","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,30]]},"article-number":"41"}}